AEGiS-PRn: Dr. Roger Hershline, Founder of CureHIV, Inc. and Global Humanceuticals, Inc., Hosting Fifth Session of the International HIV/AIDS Programs at the World AIDS Day in China, 2006

Important note: Information in this article was accurate in 2006. The state of the art may have changed since the publication date.

Dr. Roger Hershline, Founder of CureHIV, Inc. and Global Humanceuticals, Inc., Hosting Fifth Session of the International HIV/AIDS Programs at the World AIDS Day in China, 2006

PRNewswire - November 29, 2006

TIANJIN, China, Nov. 29 /PRNewswire/ -- The Chinese government has kindly invited Dr. Roger Hershline to host the Fifth Session of the International HIV/AIDS Programs Cooperation and New Technology/Product Showcase at the World AIDS Day in China, 2006. Dr. Roger Hershline will present insight into the CureHIV, Inc. public charity that he has established and describe the benefits of his new microbicide for HIV with reference to Global Humanceuticals, Inc. and China. As host of the conference he will also have the distinct honor of introducing many speakers including the world-renowned discoverer of the HIV virus, Dr. Luc Montagnier.

The conferees from more than 30 different countries are mainly professionals and executives working in the fields of HIV/AIDS diagnosis, therapy, drug design, pharmaceutical industry, policy and regulation, and venture capital companies. All of them are participating in order to look for potential opportunities for future partnerships in research, development, technology and transfer.

Being aware that Dr. Hershline's laboratory has discovered compounds as potential antiviral agents specifically for HIV/AIDS treatment, the Chinese believe that Dr. Roger Hershline's speech at the conference will be of highest interest to all other parties participating in the event and especially so to Chinese officers and researchers.

China plans to make great efforts to restrict the rapid epidemic spread of HIV/AIDS across their country, to no more than 1.5 million HIV/AIDS cases by the end of 2010. Currently, China has listed HIV/AIDS prevention and control research as key State scientific research projects to explore efficient treatment for AIDS.

The Chinese Government believes Dr. Hershline's fruitful research will be attractive and impressive to his worldwide colleagues. They have planned meetings for him with governmental and organizational officers who will introduce their domestic policies for importing antiretroviral agents and other opportunities for building cooperation partnerships.

For further information see http://www.curehiv.us

SOURCE Roger Hershline

http://www.curehiv.us

061129
PR061138

Copyright © 2006 - PRNewswire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through PRNewswire, Permissions, 810 Seventh Ave., 32nd Floor, New York, NY 10019 http://www.prnewswire.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .